Women’s Health Report Assesses first-in-class innovation with focus on endometriosis, polycystic ovarian syndrome and cervical intraepithelial neoplasia

This report assesses first-in-class innovation across the women’s health therapy area, with a particular focus on three key indications: endometriosis, polycystic ovarian syndrome (PCOS) and cervical intraepithelial neoplasia (CIN).

Pune, India - March 14, 2018 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population. Despite this, the women’s health market is relatively small. This reflects diagnostic barriers and high levels of non-treatment for women’s health disorders, as well as high levels of genericization and relatively limited innovation within recent decades.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline
Scope
• Many women’s health disorders are highly prevalent. How do epidemiology trends vary for endometriosis, PCOS and CIN?
• Innovation within women’s health has been relatively limited over recent decades. What are the most prominent unmet needs across this therapy area?
• There are 261 pipeline programs in active development for women’s health. What proportion of these products are first-in-class? How does first-in-class innovation vary by indication, development stage and molecular target class?
• Although the first-in-class pipeline is relatively modest in size it is considerably diverse with eight distinct molecular target classes represented. Which first-in-class targets have been identified as most promising for women’s health conditions?
• Over 200 licensing deals relating to women’s health have been completed since 2006. Do women’s health products typically attract high deal values? Which first-in-class products have prior deal involvement?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/987871
Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of symptoms, epidemiology, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment options.
• Visualize the composition of the women’s health market in terms of dominant molecule types and molecular targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
• Analyze the women’s health pipeline and stratify by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising first-in-class targets have been reviewed in greater detail.
• Recognize commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals, and identifying women’s health therapies that have not yet been involved in deals and may offer potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/987871

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/womens-health-report-assesses-first-in-class-innovation-with-focus-on-endometriosis-polycystic-ovarian-syndrome-and-cervical-intraepithelial-neoplasia/314337

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline%20%20

Source: MarketersMedia

Release ID: 314337

Latest News

Inquest opens into British woman poisoned by nerve agent

Jul 20, 2018

LONDON — A coroner on Thursday opened an inquest into the death of a British woman who was exposed to a military grade nerve agent, while British media reported that police may have identified suspects in an attack that poisoned a former Russian spy with the same deadly substance. Senior coroner David Ridley led a brief hearing on the death of Dawn Sturgess, but said the official cause won't be given until further tests are completed. He adjourned the proceedings until January to allow time for police inquiries to continue. Sturgess, 44, and partner Charlie Rowley, 45, collapsed on June...

Premature baby penguin recovers after parents broke her egg

Jul 20, 2018

LONDON — London Zoo says a premature baby penguin has been nursed back to health after her parents accidentally stepped on her egg and broke it. The zoo says keepers were astonished to find that the female Humboldt penguin chick, nicknamed Rainbow, was still alive inside the broken egg. They rushed the chick to the zoo's clinic, where vets transferred her to an incubation chamber. The chick spent weeks cuddling with a soft toy penguin and was fed what the zoo called "penguin milkshake" — blended fish, vitamins and minerals. Penguin keeper Suzi Hyde said Thursday that the birds typically...

Rock icon Cliff Richard wins UK High Court privacy case

Jul 20, 2018

LONDON — British rock icon Cliff Richard was awarded 210,000 pounds ($273,000) in damages Wednesday after winning a privacy lawsuit against the BBC for its coverage of a police raid at his home. Richard had sued the broadcaster for its coverage of the 2014 raid, when police were investigating alleged sex offenses. The coverage included a helicopter that circled the star's home as authorities conducted a search. The 77-year-old singer was never arrested or charged with any crime. Police don't normally identify people suspected of crimes in Britain until they are charged. His lawsuit claims he suffered "profound" damage to...

Defense contractor Raytheon reaffirms its commitment to UK

Jul 20, 2018

LONDON — U.S.-based defense contractor Raytheon says it remains committed to its operations in Britain, even as other manufacturers warn that they may curtail investment because of delays in negotiations over the country's departure from the European Union. Raytheon, whose roots in Britain go back more than 100 years, sees opportunities to expand its U.K. business, regardless of Brexit, said John Harris, chief executive of the company's international unit. Several other major firms, including Airbus and Jaguar Land Rover, have warned that the lack of certainty over Britain's future relationship with the EU could force them to leave, taking tens...

Prince Harry, Meghan visit Nelson Mandela exhibition

Jul 20, 2018

LONDON — Prince Harry and his wife Meghan have visited an exhibition in London charting the life of Nelson Mandela. Peter Hain, a former anti-apartheid campaigner and chair of the Nelson Mandela Centenary Exhibition, said it was "very fitting" for the royal couple to visit because Harry does charitable work in southern Africa, and Meghan has said that Mandela is one of her heroes. Harry has visited sites associated with Mandela, including his Robben Island prison cell, and a former Mandela aide has said that Queen Elizabeth II enjoyed a solid friendship with the South African leader. Meghan chose a...

Sign up now!